I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.

CVS Health ( CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens.

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. The Tempo system brings ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable ...